Literature DB >> 25040096

Nephrotic syndrome and acute renal failure during pegylated liposomal doxorubicin treatment.

Pierre-Louis Carron1, Marc Padilla, Jocelyne Maurizi Balzan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25040096     DOI： 10.1111/hdi.12196

Source DB:  PubMed          Journal:  Hemodial Int        ISSN： 1492-7535            Impact factor:   1.812


× No keyword cloud information.
  5 in total

Review 1.  Management of nephrotoxicity of chemotherapy and targeted agents: 2020.

Authors:  Varsha Chiruvella; Pavan Annamaraju; Achuta K Guddati
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 2.  Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity.

Authors:  Becky Meiners; Chetan Shenoy; Beshay N Zordoky
Journal:  Biol Sex Differ       Date:  2018-08-29       Impact factor: 5.027

3.  Sexual dimorphism of acute doxorubicin-induced nephrotoxicity in C57Bl/6 mice.

Authors:  Marianne K O Grant; Davis M Seelig; Leslie C Sharkey; Wan S V Choi; Ibrahim Y Abdelgawad; Beshay N Zordoky
Journal:  PLoS One       Date:  2019-02-20       Impact factor: 3.240

4.  Release of doxorubicin from its liposomal coating via high intensity ultrasound.

Authors:  Agata Mikolajczyk; Veria Khosrawipour; Joanna Kulas; Klaudia Kocielek; Pawel Migdal; Mohamed Arafkas; Tanja Khosrawipour
Journal:  Mol Clin Oncol       Date:  2019-09-05

5.  Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial.

Authors:  Eman Ghonaim; Sahar El-Haggar; Suzy Gohar
Journal:  Med Oncol       Date:  2021-08-06       Impact factor: 3.064
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.